Prostate Cancer Research Reveals Distinct Outcomes for Different Subtypes

Strategic Insights -

A new study conducted by the Global Robotics Institute has shed light on the varying outcomes of ductal adenocarcinoma (DAC) and acinar adenocarcinoma (AAC) in patients undergoing robotic-assisted radical prostatectomy (RARP). The research, published in the International Urology and Nephrology journal, found that DAC was associated with higher extracapsular extension rates and biochemical recurrence compared to AAC.

Key Takeaways:

  • The study analyzed data from 844 DAC and 14,357 AAC patients who underwent RARP between 2008 and 2023.
  • DAC was associated with higher extracapsular extension rates (48.2% vs. 35.4%, difference = 12.8%, 95% CI: 9.4-16.3, p < 0.001) and biochemical recurrence.
  • The study's findings suggest that men with DAC may require closer monitoring and specialized treatment plans.
  • The research highlights the importance of differentiating between DAC and AAC in prostate cancer diagnosis and treatment.
  • The study used a 1:1 propensity score matching method to compare outcomes between DAC and AAC patients.
  • Data was obtained from a prostate cancer referral center.

Statistics:

  • Extracapsular extension rate in DAC patients: 48.2% (vs. 35.4% in AAC patients).
  • Biochemical recurrence rate in DAC patients: [No specific data provided].
  • Number of DAC patients: 844.
  • Number of AAC patients: 14,357.
  • Median follow-up period: 4.1 years.
  • Time period of the study: 2008-2023.

Sources:

  • "Comparing the Outcomes of Ductal Versus Acinar Adenocarcinoma In Patients Undergoing Robotic-assisted Radical Prostatectomy: Propensity-matched Analysis of a Prostate Cancer Referral Center." International Urology and Nephrology, 2025.
  • Global Robotics Institute (contact: Marcio Covas Moschovas).
  • Springer (www.springer.com).
  • International Urology and Nephrology (www.springerlink.com/content/0301-1623/).